Induction of interleukin-8 secretion and apoptosis in bronchiolar epithelial cells by Fas ligation

American Journal of Respiratory Cell and Molecular Biology

Volumn 21, Issue 3, 1999, Pages 436-445

  Hagimoto, Naoki ^a   Kuwano, Kazuyoshi ^a   Kawasaki, Masayuki ^a   Yoshimi, Michihiro ^a   Kaneko, Yumi ^a   Kunitake, Ritsuko ^a   Maeyama, Takashige ^a   Tanaka, Takuo ^a   Hara, Nobuyuki ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOHEXIMIDE; DACTINOMYCIN; DNA FRAGMENT; FAS ANTIGEN; FAS LIGAND; FASLG PROTEIN, HUMAN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; PROTEIN SYNTHESIS INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; BRONCHUS; CELL CULTURE; CELL NUCLEUS; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; ELECTRON MICROSCOPY; EPITHELIUM CELL; FLOW CYTOMETRY; HUMAN; METABOLISM; PROTEIN BINDING;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD95; APOPTOSIS; BRONCHI; CELL NUCLEUS; CELLS, CULTURED; CYCLOHEXIMIDE; DACTINOMYCIN; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; EPITHELIAL CELLS; FAS LIGAND PROTEIN; FLOW CYTOMETRY; HUMANS; INTERFERON TYPE II; INTERLEUKIN-8; MEMBRANE GLYCOPROTEINS; MICROSCOPY, ELECTRON; NF-KAPPA B; PROTEIN BINDING; PROTEIN SYNTHESIS INHIBITORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033192888     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.21.3.3397     Document Type: Article

References (44)

1. Itoh, N., S. Yonehara, A. Ishii, M. Yonehara, S. Mizushima, M. Sameshima, A. Hase, Y. Seto, and S. Nagata. 1991. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66;233-243.
2. Suda, T., T. Takahashi, T. Golstein, and S. Nagata. 1993. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169-1178.
3. Hisamitsu, N., N. Hayashi, K. Katayama, K. Mochizuki, Y. Kawanishi, A. Kasahara, H. Fusamoto, and T. Kamada. 1994. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology 19:1354-1359.
4. Sayama, K., S. Yonehara, Y. Watanabe, and Y. Miki. 1994. Expression of Fas antigen on keratinocytes in vivo and induction of apoptosis in cultured keratinocytes. J. Invest. Dermatol. 103:330-334.
5. Fine, A., N. L. Anderson, T. L. Rothstein, M. C. Williams, and B. R. Gochuico. 1997. Fas expression in pulmonary alveolar type II cells. Am. J. Physiol. 273(1, Pt. 1):L64-L71.
6. Felzen, B., M. Shilkrut, H. Less, I. Sarapov, G. Maor, R. Coleman, R. B. Robinson, G. Berke, and O. Binah. 1998. Fas (CD95/Apo-1)-mediated damage to ventricular myocytes induced by cytotoxic T lymphocytes from perforin-deficient mice: a major role for inositol 1,4,5-trisphosphate. Circ. Res. 82:438-450.
7. Kuwano, K., H. Miyazaki, N. Hagimoto, M. Kawasaki, M. Fujita, R. Kunitake, Y. Kaneko, and N. Hara. 1999. The involvement of Fas-Fas ligand pathway in fibrosing lung diseases. Am. J. Respir. Cell. Mol. Biol. 20:53-60.
8. Hagimoto, N., K. Kuwano, Y. Nomoto, R. Kunitake, and N. Hara. 1997. Apoptosis and expression of Fas/Fas ligand mRNA in bleomycin-induced pulmonary fibrosis in mice. Am. J. Respir. Cell Mol. Biol. 16:91-101.
9. Wen, L. P., K. Madani, J. A. Fahrni, S. R. Duncan, and G. D. Rosen. 1997. Dexamethasone inhibits lung epithelial cell apoptosis induced by IFN-gamma and Fas. Am. J. Physiol. 273(5, Pt. 1):L921-L929.
10. Hagimoto, N., K. Kuwano, H. Miyazaki, R. Kunitake, M. Fujita, M. Kawasaki, Y. Kaneko, and N. Hara. 1997. Induction of apoptosis and pulmonary fibrosis in mice in response to ligation of Fas antigen. Am. J. Respir. Cell Mol. Biol. 17:272-278.
11. Seino, K., N. Kayagaki, K. Okumura, and H. Yagita. 1997. Antitumor effect of locally produced CD95 ligand. Nat. Med. 3:165-170.
12. Strieter, R. M., S. L. Kunkel, H. J. Showell, D. G. Remick, S. H. Phan, P. A. Ward, and R. M. Marks. 1989. Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-α, LPS, and IL-1β. Science 243:1467-1471.
13. Larsen, C. G., A. O. Anderson, E. Appella, J. J. Oppenheim, and K. Matsushima. 1989. The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science 243:1464-1466.
14. Baggioloni, M., B. Dewald, and A. Walz. 1992. Interleukin-8 and related chemotactic cytokines. In Inflammation: Basic Principles and Clinical Correlates. J. I. Gallin, I. M. Goldstein, and R. Snyderman, editors, Raven Press, New York, 247-264.
15. Car, B. D., F. Meloni, M. Luisetti, G. Semenzato, G. Gialdroni-Grassi, and A. Walz. 1994. Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Am. J. Respir. Crit. Care Med. 149(3, Pt. 1):655-659.
16. Carre, P. C., R. L. Mortenson, T. E. King, Jr., P. W. Noble, C. L. Sable, and D. W. Riches. 1991. Increased expression of the interleukin-8 gene by alveolar macrophages in idiopathic pulmonary fibrosis: a potential mechanism for the recruitment and activation of neutrophils in lung fibrosis. J. Clin. Invest. 88:1802-1810.
17. Baughman, R. P., K. L. Gunther, M. C. Rashkin, D. A. Keeton, and E. N. Pattishall. 1996. Changes in the inflammatory response of the lung during acute respiratory distress syndrome: prognostic indicators. Am. J. Respir. Crit. Care Med. 154:76-81.
18. Chollet-Martin, S., B. Jourdain, C. Gibert, C. Elbim, J. Chastre, and M. A. Gougerot-Pocidalo. 1996. Interactions between neutrophils and cytokines in blood and alveolar spaces during ARDS. Am. J. Respir. Crit. Care Med. 154(3, Pt. 1);594-601.
19. Goodman, R. B., R. M. Strieter, D. P. Martin, K. P. Steinberg, J. A. Milberg, R. J. Maunder, S. L. Kunkel, A. Walz, L. D. Hudson, and T. R. Martin. 1996. Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 154(3, Pt. 1):602-611.
20. Schutte, H., J. Lohmeyer, S. Rosseau, S. Ziegler, C. Siebert, H. Kielisch, H. Pralle, F. Grimminger, H. Morr, and W. Seeger. 1996. Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedema. Eur. Respir. J. 9:1858-1867.
21. Kwon, O. J., B. T. Au, P. D. Collins, I. M. Adcock, J. C. Mak, R. R. Robbins, K. F. Chung, and P. J. Barnes. 1994. Tumor necrosis factor-induced interleukin-8 expression in cultured human airway epithelial cells. Am. J. Physiol. 267(4, Pt. 1):L398-L405.
22. Standiford, T. J., S. L. Kunkel, M. A. Basha, S. W. Chensue, J. P. Lynch, G. B. Toews, J. Westwick, and R. M. Strieter. 1990. Interleukin-8 gene expression by a pulmonary epithelial cell line: a model for cytokine networks in the lung. J. Clin. Invest. 86:1945-1953.
23. Malinin, N. L., M. P. Boldin, A. V. Kovalenko, and D. Wallach. 1997. MAP3K-related kinase involved in NF-kappa B induction by TNF, CD95 and IL-I. Nature 385:540-544.
24. Ponton, A., M. V. Clement, and T. Stamenkovic. 1996. The CD95 (APO-1/ Fas) receptor activates NF-kappa B independently of its cytotoxic function. J. Biol. Chem. 271:8991-8995.
25. Ting, A. T., F. X. Pimentel-Muinos, and B. Seed. 1996. RIP mediates tumor necrosis factor receptor 1 activation of NF-kappa B but not Fas/APO-1-initiated apoptosis. EMBO J. 15:6189-6196.
26. Aoshiba, K., S. I. Rennard, and J. R. Spurzem. 1997. Cell-matrix and cell-cell interactions modulate apoptosis of bronchial epithelial cells. Am. J. Physiol. 272(1, Pt. 1):L28-L37.
27. Koester, S. K., P. Roth, W. R. Mikulka, S. F. Schlossman, C. Zhang, and W. F., Bolton. 1997. Monitoring early cellular responses in apoptosis is aided by the mitochondrial membrane protein-specific monoclonal antibody APO2.7. Cytometry 29:306-312.
28. Zhang, C., Z. Ao, A. Seth, and S. F. Schlossman. 1996. A mitochondrial membrane protein defined by a novel monoclonal antibody is preferentially detected in apoptotic cells. J. Immunol. 157:3980-3987.
29. Pepper, C., A. Thomas, H. Tucker, T. Hoy, and P. Bently. 1998. Flow cytometric assessment of three different methods for the measurement of in vitro apoptosis. Leuk. Res. 22:439-444.
30. Oberhammer, F., J. W. Wilson, C. Dive, I. D. Morris, J. A. Hickman, A. E. Wakeling, P. R. Walker, and M. Sikorska. 1993. Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J. 12:3679-3684.
31. Mitry, R. R., C. E. Sarraf, C. G. Wu, M. Pignatelli, and N. A. Habib. 1997. Wild-type p53 induces apoptosis in Hep3B through up-regulation of bax expression. Lab. Invest. 77:369-378.
32. Itoh, N., S. Yonehara, A. Ishii, M. Yonehara, S. Muzushima, M. Sameshima, A. Hase, Y. Seto, and S. Nagata. 1991. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233-243.
33. Abreu-Martin, M. T., A. Vidrich, D. H. Lynch, and S. R. Targan. 1995. Divergent induction of apoptosis and IL-8 secretion in HT-29 cells in response to TNF-alpha and ligation of Fas antigen. J. Immunol. 155:4147-4154.
34. Brasier, A. R., M. Jamaluddin, A. Casola, W. Duan, Q. Shen, and R. P. Garofalo. 1998. A promoter recruitment mechanism for tumor necrosis factor-alpha-induced interleukin-8 transcription in type II pulmonary epithelial cells: dependence on nuclear abundance of rel a, nf-kappa bl, and c-rel transcription factors. J. Biol. Chem. 273:3551-3561.
35. John, M., B. T. Au, P. J. Jose, S. Lim, M. Saunders, P. J. Barnes, J. A. Mitchell, M. G. Belvisi, and K. F. Chung. 1998. Expression and release of interleukin-8 by human airway smooth muscle cells; inhibition by Th-2 cytokines and corticosteroids. Am. J. Respir. Cell Mol. Biol. 18:84-90.
36. Keltritz, R., M. L. Gaido, H. Haller, F. C. Luft, C. J. Jenette, and R. J. Falk. 1998. Interleukin-8 delays spontaneous and tumor necrosis factor-alpha-mediated apoptosis of human neutrophils, Kidney Int. 53:84-91.
37. Kiener, P. A., P. Moran-Davis, B. M. Rankin, A. F. Wahl, A. Aruffo, and D. Hollenbaugh. 1995. Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes. J. Immunol. 155: 4917-4925.
38. Hsu, H., H. B. Shu, M. G. Pan, and D. V. Goeddel. 1996. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor-1 signal transduction pathways. Cell 84:299-308.
39. Rothe, M., V. Sarma, V. M. Dixit, and D. V. Goeddel. 1995. TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40. Science 269: 1424-1427.
40. Clement, M. V., and I. Stamenkovic. 1994. Fas and tumor necrosis factor receptor-mediated cell death: similarities and distinctions. J. Exp. Med. 180:557-567.
41. Kang, S. M., D. B. Schneider, Z. Lin, D. Hanahan, D. A. Dichek, P. G. Stock, and S. Backkeskov. 1997. Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction. Nat. Med. 3:738-743.
42. Allison, J., H. M. Georgiou, A. Strasser, and D. L. Vaux. 1997. Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts. Proc. Natl. Acad. Sci. USA 94:3943-3947.
43. Matsushima, K., and J. J. Oppenheim. 1989. Interleukin-8 and MCAF: novel inflammatory cytokines inducible by IL 1 and TNF. Cytokine 1:2-13.
44. Kunkel, S. L., T. Standiford, K. Kasahara, and R. M. Strieter. 1991. Interleukin-8 (IL 8): the major neutrophil chemotactic factor in the lung. Exp. Lung Res. 17:17-23.